Natera is trading 4.2% up at $428.12 on October 28, 2026, with no clearly attributable company-specific catalyst identified for the move.

  • XBI is up 2.18%, while Natera’s gain is larger.
  • Recent attention includes positive oncology findings presented at ESMO and analyst target increases reported October 27; neither establishes a direct cause for today’s move.